85 related articles for article (PubMed ID: 3590078)
21. Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins.
Bladbjerg EM; Tholstrup T; Marckmann P; Sandström B; Jespersen J
Thromb Haemost; 1995 Feb; 73(2):239-42. PubMed ID: 7792736
[TBL] [Abstract][Full Text] [Related]
22. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
Halbmayer WM; Haushofer A; Toth E
Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
[TBL] [Abstract][Full Text] [Related]
23. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
24. Differences in reactivity to vitamin K administration of the vitamin K-dependent procoagulant factors, protein C and S, and osteocalcin.
Shirakawa Y; Shirahata A; Fukuda M
Semin Thromb Hemost; 2000; 26(1):119-26. PubMed ID: 10805293
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
26. Transient ischemic attack in a patient with congenital protein-C deficiency during treatment with stanozolol.
De Stefano V; Leone G; Teofili L; Ferrelli R; Pollari G; Antonini V; Bizzi B
Am J Hematol; 1988 Oct; 29(2):120-1. PubMed ID: 3189300
[TBL] [Abstract][Full Text] [Related]
27. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery.
Raivio P; Fernández JA; Kuitunen A; Griffin JH; Lassila R; Petäjä J
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):44-51. PubMed ID: 17198779
[TBL] [Abstract][Full Text] [Related]
28. Protein C antigen levels in major abdominal surgery: relationships to deep vein thrombosis, malignancy and treatment with stanozolol.
Blamey SL; Lowe GD; Bertina RM; Kluft C; Sue-Ling HM; Davies JA; Forbes CD
Thromb Haemost; 1985 Oct; 54(3):622-5. PubMed ID: 3911479
[TBL] [Abstract][Full Text] [Related]
29. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
[TBL] [Abstract][Full Text] [Related]
30. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R
Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603
[TBL] [Abstract][Full Text] [Related]
31. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
32. Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC Subcommittee on Protein C and Protein S. Protein C Transmitter Study Group.
Pabinger I; Allaart CF; Hermans J; Briët E; Bertina RM
Thromb Haemost; 1992 Oct; 68(4):470-4. PubMed ID: 1448781
[TBL] [Abstract][Full Text] [Related]
33. Hereditary protein S deficiency and venous thrombo-embolism. A study in three Dutch families.
Broekmans AW; Bertina RM; Reinalda-Poot J; Engesser L; Muller HP; Leeuw JA; Michiels JJ; Brommer EJ; Briët E
Thromb Haemost; 1985 Apr; 53(2):273-7. PubMed ID: 3161207
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency.
Winter JH; Fenech A; Bennett B; Douglas AS
Br J Haematol; 1984 Jul; 57(3):527-37. PubMed ID: 6743570
[TBL] [Abstract][Full Text] [Related]
35. Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification.
Marlar RA; Adcock DM; Madden RM
Thromb Haemost; 1990 Jun; 63(3):375-9. PubMed ID: 2402741
[TBL] [Abstract][Full Text] [Related]
36. [Generation of blood anticoagulant and fibrinolytic activity after intravenous administration of protein C-a in rats].
Kogan AE; Strukova SM
Biull Eksp Biol Med; 1989 Jan; 107(1):3-5. PubMed ID: 2914169
[TBL] [Abstract][Full Text] [Related]
37. [Congenital protein C deficiency and thromboembolic diseases].
Schwieder G; Vieregge P; Wiedemann G; Wagner T
Dtsch Med Wochenschr; 1987 Mar; 112(11):425-8. PubMed ID: 3816591
[TBL] [Abstract][Full Text] [Related]
38. The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
Small M; Lowe GD; MacCuish AC; Forbes CD
Thromb Res; 1986 Oct; 44(2):253-9. PubMed ID: 3787569
[No Abstract] [Full Text] [Related]
39. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants.
Brenner B; Tavori S; Zivelin A; Keller CB; Suttie JW; Tatarsky I; Seligsohn U
Br J Haematol; 1990 Aug; 75(4):537-42. PubMed ID: 2145029
[TBL] [Abstract][Full Text] [Related]
40. [A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].
Sakata T; Katayama Y; Matsuyama T; Hatanaka K
Rinsho Byori; 1990 Oct; 38(10):1198-200. PubMed ID: 2262977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
